Event
Date
Tuesday, 4 March 2025
Time
1 - 2pm GMT
Location
Online
Price
Free admission
The UK has been at the forefront of the social prescribing movement, a type of personalised care which connects individuals with non-clinical supports and services within the community to address diverse health and social needs.
An estimated three million people in the UK have received social prescribing since the UK government announced a radical, major investment in social prescribing in 2019 as part of its NHS Long Term Plan. But there has been much controversy about whether social prescribing can genuinely address health needs or instead presents an unregulated service potentially even exacerbating health inequalities.
Prof Daisy Fancourt, one of the world’s leading scholars in the field of arts and health, will consider the findings to date, including the substantial body of clinical trials and epidemiological analyses led by UCL’s Social Biobehavioural Research Group.
Prof Daisy Fancourt
Prof Daisy Fancourt is Professor of Psychobiology & Epidemiology at UCL and Head of the Social Biobehavioural Research Group. Her research focuses on the effects of social behaviours on health, including loneliness, social isolation, leisure activities, arts and cultural engagement, and social prescribing. Daisy has received over £30m in research funding and her work has been recognised with over two dozen national and international research awards.
She is Director of the World Health Organisation Collaborating Centre on Arts and Health, a Technical Advisor to the WHO, a scientific adviser to UK Government, a BBC New Generation Thinker, and a World Economic Forum Global Shaper. Daisy has published over 300 peer-reviewed papers and given over 50 keynotes around the world. She is listed by Clarivate as one of the most highly cited scientists in the world.
